Cognitive and Behavioral Treatments for Anxiety and Depression in a Patient with an Implantable Cardioverter Defibrillator (ICD): A Case Report and Clinical Discussion

Hirsh, Adam T.; Sears, Samuel F.; Conti, Jamie B.

doi:10.1007/s10880-009-9160-0

Cited by 15 publications

(13 citation statements)

References 32 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…FSAS scores may be a useful barometer of treatment response, as ICD‐specific cognitive–behavioral interventions in small samples have been associated with decreased FSAS scores . However, there have been inconsistent results on the short‐term and long‐term efficacy of ICD‐specific web‐based psychological and educational interventions for reducing ICD‐related distress, including FSAS score …”

Section: Resultsmentioning

confidence: 99%

“…Although not developed specifically for this purpose, research on FSAS suggests that it may be a viable measure for monitoring and tracking treatment response to cognitive–behavioral interventions and education‐based interventions . As such, tools like FSAS may help foster measurement‐based care in cardiac psychology; this is a critical component of high‐quality, evidence‐based service delivery that is sorely needed.…”

Section: Discussionmentioning

confidence: 99%

“…Although not developed specifically for this purpose, research on FSAS suggests that it may be a viable measure for monitoring and tracking treatment response to cognitive-behavioral interventions 23 proposed trial of bundled payments for coronary artery bypass graft surgery). 34 Despite this movement, the uptake of measurement-based care by behavioral health providers, including those in cardiology, is lagging.…”

Section: Future Directionsmentioning

confidence: 99%

See 2 more Smart Citations

Measuring ICD shock anxiety: Status update on the Florida Shock Anxiety Scale after over a decade of use

Tripp

Huber

Kuhl³

et al. 2019

Pacing Clinical Electrophis

Self Cite

View full text Add to dashboard Cite

Introduction Approximately 44% of patients with implantable cardioverter defibrillators (ICDs) experience some form of shock anxiety, associated with cardiac fear, physical inactivity, and increased morbidity and mortality. The Florida Shock Anxiety Scale (FSAS) was created to measure ICD‐specific fears for a more precise target of patient psychologic distress and potential need for intervention. The current paper describes results from a focused literature review of studies using FSAS over the past 15 years, with the aim of summarizing its current reliability and validity, associated outcomes, and potential future directions for its clinical and research implementation. Methods In this review, 26 peer‐reviewed articles were analyzed and selected from an in‐depth literature search of two electronic databases. Results The reliability and validity of FSAS has been upheld since its initial validation and remain positive. The majority of studies used FSAS as an assessment tool to evaluate a clinical need for psychologic support or psychoeducation. The most frequently reported predictors of FSAS shock anxiety include experience of shock, appropriate and inappropriate, and number of shocks experienced. Common correlates of higher FSAS scores include lower device‐related knowledge, lower perceived support from healthcare providers, greater posttraumatic stress disorder symptoms, and negative attitudes about device dependency. Younger age and female gender are also associated with increased shock anxiety. Conclusions Since 2006, FSAS has been widely represented as a valid and reliable assessment tool for quantifying device‐related anxiety in ICD recipients in diverse populations. Future directions for FSAS should explore its potential role in support of measurement‐based care.

show abstract

Section: Resultsmentioning

confidence: 99%

Section: Discussionmentioning

confidence: 99%

Section: Future Directionsmentioning

confidence: 99%

See 1 more Smart Citation

Measuring ICD shock anxiety: Status update on the Florida Shock Anxiety Scale after over a decade of use

Tripp

Huber

Kuhl³

et al. 2019

Pacing Clinical Electrophis

Self Cite

View full text Add to dashboard Cite

show abstract

“…There is evidence that patients experiencing anxiety or depression after ICD implantation can be assisted through therapeutic intervention (Hirsh et al, 2009).…”

Section: Psychological Therapymentioning

confidence: 99%

ICD surgery: highlighting the psychological consequences

Jackson

Murphy

2017

British Journal of Cardiac Nursing

View full text Add to dashboard Cite

C oronary heart disease (CHD) is the most common clinical condition associated with sudden cardiac death (SCD), with approximately 80% of such deaths linked to CHD (Chugh et al, 2008). CHD can lead to ventricular tachycardia (VT) (an abnormally fast heart rhythm originating in one of the ventricles), and ventricular fibrillation (VF) (an uncoordinated and erratic contraction of the heart muscle of the ventricles)-both of these can cause SCD. Patients with cardiomyopathies account for a further 10-15% of cases of SCD; there is significant overlap between this group and patients with CHD. The remaining 5-10% of SCDs are associated with other disorders, which are either structurally abnormal congenital cardiac conditions or structurally normal, but electrically abnormal, heart conditions (Chugh et al, 2008). In more than 30% of SCDs, however, patients have no previous diagnosis of heart disease (Myerburg and Junttila, 2012). Primary and secondary prevention of SCD An implantable cardioverter defibrillator (ICD) can terminate episodes of ventricular tachycardia or fibrillation, so reduce the risk of sudden death in patients with a range of cardiac conditions.

show abstract

“…There were two randomised controlled trials (RCTs), 15 16 one prospective observational study, 17 one cross-sectional study, 18 four case-control studies [19][20][21][22] and three case studies. [23][24][25] These studies suffer from methodological limitations, which is why conclusive evidence does not exist. However, the two RCTs both find a significant difference in anxiety over time in the CBT group compared with the control group.…”

Section: Introduction Background and Rationalementioning

confidence: 99%

The Screen-ICD trial. Screening for anxiety and cognitive therapy intervention for patients with implanted cardioverter defibrillator (ICD): a randomised controlled trial protocol

et al. 2016

View full text Add to dashboard Cite

IntroductionPrevious research shows that patients with an implanted cardioverter defibrillator (ICD) have a fourfold increased mortality risk when suffering from anxiety compared with ICD patients without anxiety. This research supports the screening of ICD patients for anxiety with the purpose of starting relevant intervention.Methods and analysisScreen-ICD consists of 3 parts: (1) screening of all hospitalised and outpatient patients at two university hospitals using the Hospital Anxiety and Depression Scale (HADS), scores ≥8 are invited to participate. (2) Assessment of type of anxiety by Structured Clinical Interview for DSM Disorders (SCID). (3) Investigator-initiated randomised clinical superiority trial with blinded outcome assessment, with 1:1 randomisation to cognitive–behavioural therapy (CBT) performed by a cardiac nurse with CBT training, plus usual care or usual care alone. The primary outcome is HADS-A measured at 16 weeks. Secondary outcomes include Becks Anxiety Inventory, HeartQoL, Hamilton Anxiety Scale, heart rate variability, ICD shock, time to first shock and antitachycardia pacing. A total of 88 participants will be included. The primary analyses are based on the intention-to-treat principle and we use a mixed model with repeated measurements for continuous outcomes. For binary outcomes (HADS-A score <8), we use a generalised mixed model with repeated measurements.Ethics and disseminationThe trial is performed in accordance with the Declaration of Helsinki. All patients must give informed consent prior to participation and the trial is initiated after approval by the Danish Data Protection Agency (RH-2015-282) and the regional ethics committee (H-16018868). Positive, neutral and negative results of the trial will be published.Trial registration numberNCT02713360.

show abstract

Cognitive and Behavioral Treatments for Anxiety and Depression in a Patient with an Implantable Cardioverter Defibrillator (ICD): A Case Report and Clinical Discussion

Cited by 15 publications

References 32 publications

Measuring ICD shock anxiety: Status update on the Florida Shock Anxiety Scale after over a decade of use

Measuring ICD shock anxiety: Status update on the Florida Shock Anxiety Scale after over a decade of use

ICD surgery: highlighting the psychological consequences

The Screen-ICD trial. Screening for anxiety and cognitive therapy intervention for patients with implanted cardioverter defibrillator (ICD): a randomised controlled trial protocol

Contact Info

Product

Resources

About